Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced a series of key senior ...

Cardiovascular disease remains a major concern in cities, with poor outcomes and high societal cost often driven by unequal access to healthcare.  A pan-European consortium of 34 international ...

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in epigenetics and AI-driven Precision Cardiovascular Medicine, Aimil Ltd., a company at the forefront of the instrumentation industry in ...

Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. PrecisionCHD is a clinical blood test that can detect CHD at a ...

Unfortunately you've used all of your gifts this month. Your counter will reset on the first day of next month.

Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 clinical labs and more than 300 doctors to expand the reach of its precision ...

Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in ...

NEW YORK – Cardio Diagnostics announced on Wednesday that it has partnered with Indian instrumentation firm Aimil and clinical laboratory network Dr. Lal PathLabs to launch the PrecisionCHD test for ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.